Ipsen
* Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales close to ó1.6 billion in 2016, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,100 employees worldwide. * Ipsen est un groupe biopharmaceutique mondial de sp_cialit_ focalis_ sur lÍinnovation et la m_decine de sp_cialit_. Il d_veloppe et commercialise des m_dicaments innovants dans trois domaines th_rapeutiques cibl_s _ lÍoncologie, les neurosciences et les maladies rares. LÍengagement dÍIpsen en oncologie est illustr_ par son portefeuille croissant de th_rapies visant ö am_liorer la vie des patients souffrant de cancers de la prostate, de tumeurs neuroendocrines, de cancers du rein et du pancr_as. Ipsen b_n_ficie _galement dÍune pr_sence significative en Sant_ Familiale. Avec un chiffre dÍaffaires de prs de 1,6 milliard dÍeuros en 2016, Ipsen commercialise plus de 20 m_dicaments dans plus de 115 pays, avec une pr_sence commerciale directe dans plus de 30 pays. La R&D d'Ipsen est focalis_e sur ses plateformes technologiques diff_renci_es et innovantes situ_es au cìur des clusters mondiaux de la recherche biotechnologique et en sciences de la vie (Paris-Saclay, France ; Oxford, Royaume-Uni; Cambridge, Etats-Unis). Le Groupe rassemble environ 5 100 collaborateurs dans le monde.
5,000 - 10,000
Boulogne-Billancourt, France
About

* Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales close to ó1.6 billion in 2016, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,100 employees worldwide.

* Ipsen est un groupe biopharmaceutique mondial de sp_cialit_ focalis_ sur lÍinnovation et la m_decine de sp_cialit_. Il d_veloppe et commercialise des m_dicaments innovants dans trois domaines th_rapeutiques cibl_s _ lÍoncologie, les neurosciences et les maladies rares. LÍengagement dÍIpsen en oncologie est illustr_ par son portefeuille croissant de th_rapies visant ö am_liorer la vie des patients souffrant de cancers de la prostate, de tumeurs neuroendocrines, de cancers du rein et du pancr_as. Ipsen b_n_ficie _galement dÍune pr_sence significative en Sant_ Familiale. Avec un chiffre dÍaffaires de prs de 1,6 milliard dÍeuros en 2016, Ipsen commercialise plus de 20 m_dicaments dans plus de 115 pays, avec une pr_sence commerciale directe dans plus de 30 pays. La R&D d'Ipsen est focalis_e sur ses plateformes technologiques diff_renci_es et innovantes situ_es au cìur des clusters mondiaux de la recherche biotechnologique et en sciences de la vie (Paris-Saclay, France ; Oxford, Royaume-Uni; Cambridge, Etats-Unis). Le Groupe rassemble environ 5 100 collaborateurs dans le monde.

Site Traffic
  • 504567 Global Rank
  • 81862
    France
  • 79.2 K Estimated Visits
Traffic Sources
  • Search
    54.14%
  • Direct
    18.96%
  • Social
    13.97%
  • Referrals
    10.16%
  • Mail
    2.77%
  • Display
    0.00%
Geography Breakdown
Powered by
Alexa Traffic Data
Global Rank 207,180
1,074,061
India Rank 101,613
1,268
India Page Views 37.4%
1.6%
Top Countries
Top Search Keywords
  • Grand Rapids
Mobile App Data
MixRank is the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn more.
  • 27 SDKs
  • 2 Total reviews
  • App Url: https://itunes.apple.com/app/ipsen/id685380639
  • App Support: https://www.ipsen.com
  • Genre: Medical
  • Bundle ID: com.ipsen.ullistouchipad
  • Version: 1.9
  • Release Date: August 20th, 2013
  • Update Date: January 29th, 2016

Description:

This application has been developed for physicians as a medical education tool. It is an interactive anatomical atlas of the upper and lower limb muscles related to Spasticity. One section of the atlas details the muscle system of the upper and lower limbs with different ways to find each muscle (by name or location). As well as identifying where a muscle is located, additional information is provided for each muscle (origin, insertion, action, nerve supply and arterial supply). The second section of the atlas identifies muscles involved in the different forms of Spasticity. This application is for health care professionals only.

Daily Downloads Dec 01 - 31, 2024

Sort by

Nov 29, 2014

Please wait loading

Writes please wait loading. Please correct

Feb 12, 2014

Does not work

The app doesn't work on iOS 8.1.1. It starts and then freezes on loading something. Please fix the bug.
Accounts Framework
The Accounts framework provides access to user accounts stored in the Accounts database. An account stores the login credentials of a particular service, such as Twitter, that can be used as authentication for the service. By implementing the Accounts framework into your app, you do not need to be responsible for storing account logins yourself. Instead, the user can grant access for your app to use their account login credentials, bypassing the need to type their username and password. If no account for a particular service exists in the user’s Accounts database, you can let them create and save an account from within your app.
Akamai
Get intelligent performance optimizations for superior web and mobile app experiences. Ion, Akamai’s flagship performance solution, is a suite of intelligent performance optimizations that helps deliver superior website and mobile app experiences. Built on the globally distributed and near-infinitely scalable Akamai Intelligent Edge Platform™, Ion continuously monitors real user behavior, applying best practice performance optimizations automatically and adapting in real time to changes in content, user behavior, and connectivity.
AudioToolbox
The Audio Toolbox framework provides interfaces for recording, playback, and stream parsing. In iOS, the framework provides additional interfaces for managing audio sessions.
AVFoundation
The AV Foundation framework provides an Objective-C interface for managing and playing audio-visual media in iOS and OS X applications.
ccuiio
CFNetwork
Core Foundation Framework
Core Foundation is a framework that provides fundamental software services useful to application services, application environments, and to applications themselves. Core Foundation also provides abstractions for common data types, facilitates internationalization with Unicode string storage, and offers a suite of utilities such as plug-in support, XML property lists, URL resource access, and preferences.
Core Graphics
The Core Graphics framework is based on the Quartz advanced drawing engine. It provides low-level, lightweight 2D rendering with unmatched output fidelity. You use this framework to handle path-based drawing, transformations, color management, offscreen rendering, patterns, gradients and shadings, image data management, image creation, and image masking, as well as PDF document creation, display, and parsing.
DCProgressView
Custom ProgressView inspired by twitter bootstrap.
Facebook
The iOS SDK provides Facebook Platform support for iOS apps.
Flurry
Flurry SDK for analytics tracking and reporting. FlurryAds SDK also included.
Foundation Framework
Data sourced from MixRank, the most comprehensive database of mobile apps, developers, SDKs, technologies, services, and integrations. Learn More.
Ipsen receives up to 0.08M pageviews per day.

They are headquartered at Boulogne-Billancourt, France, and have 16 advertising & marketing contacts listed on Kochava. Ipsen works with Advertising technology companies such as Chango, Turn, AOL-Time Warner Online Advertising, BlueKai, AppNexus, Atlas, DoubleClick.Net, DemDex, Resonate Insights, Dstillery, The Trade Desk, BlueKai DMP, LinkedIn Ads, Twitter Ads.